# Soligenix (SNGX) — News

SNGX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sngx/news

## Recent headlines

- [Soligenix Inc - files for offering of up to $2.5 mln common stock - SEC filing](https://www.ainvest.com/news/soligenix-files-offering-2-5-mln-common-stock-sec-filing-2606) — AInvest Wire, Jun 26, 2026
- Soligenix stock soars 300% on positive HyBryte study results — AInvest Wire, Jul 9, 2024
- Soligenix FY GAAP EPS $(0.79) Beats $(0.82) Estimate, Sales $800.00K Beat $797.50K Estimate — AInvest Wire, Mar 15, 2024
- **Important** — Soligenix shares rise 19% after vaccine trial shows protection against two viruses — AInvest Wire, Jan 2, 2024
  Soligenix shares rise 19% after vaccine trial shows protection against two viruses Soligenix, a late-stage biopharmaceutical company, has recently announced the publication of a study demonstrating the efficacy of a single-vial, bivalent vaccine against two lethal viruses, Sudan ebolavirus (SUDV)…
- Soligenix climbs 20% premarket after announcing publication demonstrating complete protection against filovirus disease in nonhuman primate models of Ebola and Marburg viruses — AInvest Wire, Jan 2, 2024
  Soligenix climbs 20% premarket after announcing publication demonstrating complete protection against filovirus disease in nonhuman primate models of Ebola and Marburg viruses Soligenix, a late-stage biopharmaceutical company, recently announced that its thermostabilized bivalent and trivalent…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).